Test plan area: Health Promotion and Maintenance

Difficulty level: Intermediate

The clinical most obvious manifestation of kidney stones is:

Choice A reason: The primary distinction between ALL and AML is the type of cell that becomes cancerous. Acute Lymphocytic Leukemia (ALL) affects the lymphoid cell line. Lymphoid cells, or lymphocytes, are a type of white blood cell that plays a crucial role in the immune system, helping the body to fight infections. There are three types of lymphocytes: B cells, T cells, and natural killer (NK) cells. In ALL, the malignant transformation of these lymphocytes occurs, leading to an overproduction of immature lymphoid cells, or lymphoblasts. These lymphoblasts crowd out normal blood cells in the bone marrow, leading to symptoms such as anemia, susceptibility to infections, and easy bruising or bleeding.

Choice B reason: While it is true that ALL is more prevalent in children and AML is more common in adults, this age distribution is not the primary distinguishing feature between the two types of leukemia. ALL represents about 75% of pediatric leukemia cases, typically affecting children between 2 and 5 years old, while AML is more commonly diagnosed in adults, with the incidence increasing with age. However, both types can occur at any age, and the age of onset alone is not sufficient to distinguish between them. The differentiation based on cell type remains the most significant factor.

Choice C reason: Clinical manifestations of ALL and AML can be very similar because both involve the proliferation of immature white blood cells in the bone marrow, which disrupts normal blood cell production. Common symptoms include fatigue, frequent infections, fever, weight loss, easy bruising or bleeding, and bone pain. These symptoms result from the overproduction of immature leukemic cells and the subsequent suppression of normal hematopoiesis. Although there may be some differences in presentation based on the specific cell types involved, clinical manifestations are not the primary basis for differentiating between ALL and AML.

Choice D reason: The diagnostic tests used for ALL and AML are quite similar and typically include complete blood counts (CBC), bone marrow biopsy, and flow cytometry to identify the types of cells involved. Cytogenetic and molecular studies are also used to detect specific genetic abnormalities associated with each type of leukemia. While certain markers and genetic mutations may differ between ALL and AML, the overall approach to diagnosis involves similar testing methods. Therefore, the primary difference between the two leukemias lies in the cell type affected rather than the specific diagnostic tests used.

Choice A reason: Infection in the nerve fibers is not a primary cause of diabetic neuropathy. While infections can affect nerves, diabetic neuropathy is primarily due to vascular complications and chronic hyperglycemia, not infections.

Choice B reason: Inability to provide continuous glucose to the brain and spinal cord is not a cause of neuropathy. The brain and spinal cord typically have a continuous supply of glucose. Neuropathy in diabetes results from the damage to peripheral nerves due to prolonged high blood glucose levels and subsequent vascular complications.

Choice C reason: Excessive glucose exposure to the brain and spinal cord is not directly related to neuropathy. The neuropathic complications in diabetes are due to the damage of peripheral nerves caused by hyperglycemia and vascular insufficiency, rather than glucose affecting the central nervous system.

Choice D reason: Thickening and ischemia of the vessels that supply the nerve fibers are the primary causes of diabetic neuropathy. Chronic hyperglycemia leads to damage of the small blood vessels (vasa nervorum) that supply the nerves, resulting in reduced blood flow and oxygen supply to the nerves. This ischemia causes nerve degeneration, delayed nerve conduction, and impaired sensory function, which are characteristic of diabetic neuropathy.